These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33882857)

  • 21. Genetic Characteristics of Incidental Pheochromocytoma and Paraganglioma.
    Zhang J; Li M; Pang Y; Wang C; Wu J; Cheng Z; Li X; Lu Z; Liu Y; Guo J; Chen X; He Y; Guan X; Xu X; Wang Y; Liu J; Guo W; Hou Y; Liu L; Jiang J; Gao X
    J Clin Endocrinol Metab; 2022 Apr; 107(5):e1835-e1842. PubMed ID: 35106577
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonselective Compared With Selective α-Blockade Is Associated With Less Intraoperative Hypertension in Patients With Pheochromocytomas and Paragangliomas: A Retrospective Cohort Study With Propensity Score Matching.
    Kong H; Li N; Yang XC; Nie XL; Tian J; Wang DX
    Anesth Analg; 2021 Jan; 132(1):140-149. PubMed ID: 32675634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pheochromocytoma/paraganglioma-associated cardiomyopathy.
    Szatko A; Glinicki P; Gietka-Czernel M
    Front Endocrinol (Lausanne); 2023; 14():1204851. PubMed ID: 37522121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Catecholamine-induced cardiomyopathy: an endocrinologist's perspective.
    Kumar A; Pappachan JM; Fernandez CJ
    Rev Cardiovasc Med; 2021 Dec; 22(4):1215-1228. PubMed ID: 34957765
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pheochromocytoma and paraganglioma: An emerging cause of secondary osteoporosis.
    Yokomoto-Umakoshi M; Umakoshi H; Fukumoto T; Matsuda Y; Nagata H; Ogata M; Kawate H; Miyazawa T; Sakamoto R; Ogawa Y;
    Bone; 2020 Apr; 133():115221. PubMed ID: 31940499
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical profiles of patients with surgically resected pheochromocytoma and paraganglioma.
    Lee SH; Park JH; Lee JY; Lee SR; Rhee KS; Chae JK; Kim WH; Sul JY; Oh JK; Kwon HJ; Lee JH; Seong IW
    Korean J Intern Med; 2020 Mar; 35(2):351-359. PubMed ID: 30808127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
    Lenders JW; Duh QY; Eisenhofer G; Gimenez-Roqueplo AP; Grebe SK; Murad MH; Naruse M; Pacak K; Young WF;
    J Clin Endocrinol Metab; 2014 Jun; 99(6):1915-42. PubMed ID: 24893135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic disorders in patients with pheochromocytomas and sympathetic paragangliomas.
    Araujo-Castro M; Mínguez Ojeda C; García Centeno R; López-García MC; Lamas C; Hanzu FA; Mora M; Del Castillo Tous M; Rodríguez de Vera Gómez P; Parra Ramírez P; Alvarez-Escola C; Blanco Carrera C; Barahona San Millán R; Recasens M; Valdés N; Gracia Gimeno P; de Miguel Novoa P; Vicente A; Manjón L; García Sanz I; Michalopoulou T; Calatayud M
    Endocr Relat Cancer; 2022 Dec; 29(12):645-655. PubMed ID: 36069783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Metastatic risk factors in pheochromocytoma/paraganglioma].
    Rebrova DV; Loginova OI; Vorobyev SL; Vorokhobina NV; Kozorezova ES; Indeykin FA; Savelyeva TV; Sleptsov IV; Chernikov RA; Fedorov EA; Semenov AA; Chinchuk IK; Shikhmagomedov SS; Alekseev MA; Krasnov LM; Rusakov VF
    Probl Endokrinol (Mosk); 2023 Oct; 70(2):37-45. PubMed ID: 38796759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNA-210 May Be a Preoperative Biomarker of Malignant Pheochromocytomas and Paragangliomas.
    Ruff SM; Ayabe RI; Malekzadeh P; Good ML; Wach MM; Gonzales MK; Tirosh A; Nilubol N; Pacak K; Kebebew E; Patel D
    J Surg Res; 2019 Nov; 243():1-7. PubMed ID: 31146085
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas.
    Y-Hassan S; Falhammar H
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Somatic IDH1 Hotspot Variants in Chinese Patients With Pheochromocytomas and Paragangliomas.
    Li M; He Y; Pang Y; Zhang J; Feng Y; He Y; Xu X; Wei Y; Zhong D; Deng W; Wang L; Yan B; Jiang Y; Xu N; Cai H; Wen Y; Ning J; Liu Y; Gao X; Shan Z; Liu L; Teng X; Richter S; Jiang J
    J Clin Endocrinol Metab; 2023 Apr; 108(5):1215-1223. PubMed ID: 36355572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pheochromocytoma presenting as inverted Takotsubo cardiomyopathy: a case report and review of the literature.
    Gervais MK; Gagnon A; Henri M; Bendavid Y
    J Cardiovasc Med (Hagerstown); 2015 Jan; 16 Suppl 2():S113-7. PubMed ID: 20154633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of Intraoperative Hemodynamic Instability in Postoperatively Diagnosed Pheochromocytoma and Sympathetic Paraganglioma Patients.
    Kim JH; Lee HC; Kim SJ; Lee KE; Jung KC
    Front Endocrinol (Lausanne); 2022; 13():816833. PubMed ID: 35282440
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent Disease in Patients With Sporadic Pheochromocytoma and Paraganglioma.
    Li M; Prodanov T; Meuter L; Kerstens MN; Bechmann N; Prejbisz A; Remde H; Timmers HJLM; Nölting S; Talvacchio S; Berends AMA; Fliedner S; Robledo M; Lenders JWM; Pacak K; Eisenhofer G; Pamporaki C
    J Clin Endocrinol Metab; 2023 Jan; 108(2):397-404. PubMed ID: 36190922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
    Schreiner F; Beuschlein F
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101347. PubMed ID: 31662271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors.
    Yu R; Nissen NN; Bannykh SI
    Endocr Pract; 2012; 18(4):483-92. PubMed ID: 22297057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma.
    Rao D; Peitzsch M; Prejbisz A; Hanus K; Fassnacht M; Beuschlein F; Brugger C; Fliedner S; Langton K; Pamporaki C; Gudziol V; Stell A; Januszewicz A; Timmers HJLM; Lenders JWM; Eisenhofer G
    Eur J Endocrinol; 2017 Aug; 177(2):103-113. PubMed ID: 28476870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The clinical characteristics of patients with normotension in pheochromocytomas and paragangliomas.
    Zhao L; Zhang T; Meng X; Fan H; Zhang Z; Liu Y; Zhou X; Zhu H
    Endocrine; 2023 Apr; 80(1):174-182. PubMed ID: 36749542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in Cardiac Deformation, Timing of Contraction and Relaxation, and Early Myocardial Fibrosis Accompany the Apparent Recovery of Acute Stress-Induced (Takotsubo) Cardiomyopathy: An End to the Concept of Transience.
    Schwarz K; Ahearn T; Srinivasan J; Neil CJ; Scally C; Rudd A; Jagpal B; Frenneaux MP; Pislaru C; Horowitz JD; Dawson DK
    J Am Soc Echocardiogr; 2017 Aug; 30(8):745-755. PubMed ID: 28599831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.